a
NAME OF THE INTERMEDIATES CAS NO END PRODUCT
7-Methoxy-1-naphthylacetonitrile 138113-08-3 Agomelatine
N-Methylcarbonyl-2-Chloroacetamidrazone 155742-64-6 Aprepitant
(2R,3S)-2-[(1R)-1-[3,5-is(trifluoromethyl)phenyl]ethoxy]-
3-(4-fluorophenyl)morpholine hydrochloride
171482-05-6 Aprepitant
1-[4-(2-Azepan-1-yl-ethoxy)-benzyl]-5-benzyloxy-
2-(4-benzyloxy -phenyl)-3-methyl-1h-indole
198480-21-6 Bazedoxifene
3-Acetyl-2-(aminosulfonyl)-5-chlorothiophene 160982-10-5 Brinzolamide
3-(2-Bromoacetyl)-5-chlorothiophene-2-sulfonamide, 160982-11-6 Brinzolamide
3-(3'-Trifluoromethylphenyl)propanol 78573-45-2 Cinacalcet
3-[(3-Amino-4-methylaminobenzoyl)
pyridine-2-ylamino]propionic acid with ethyl ester
212322-56-0 Dabigatran
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-
5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride
211914-50-0 Dabigatran
1-(1,2,3,6-Tetrahydro-4-pyridyl)-2-Benzimidazolione 2147-83-3 Droperidol
1-{(4-methyl-quianazolin-2yl)methyl}-3-methyl-7-
(2-butyn-1-yl)-8-bromo-xanthine
853029-57-9 Linagliptin
Tert-butyl (R)-piperidin-3-ylcarbamate/(R)-piperidin-
3-amine dihydrochloride
334618-23-4 Linagliptin
(1R)-2-{[2-(4-aminophenyl)ethyl]amino}-1-phenylethanol HCL 521284-22-0 Mirabegron
(S-1-decyn-O-tert dimethyl silyl-2-yl-5-ol Prostaglandin
5-Bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine 380380-64-3 Tedizolid
  • Remarks:


    * Under development/evaluation. ✔ Available.

    Patent:All transactions are carried out in conformity with patent laws applicable in the user country, responsibility with respect to third parties rights in a specific country lies exclusively with the user.

    The above products are offered as per BP/EP/USP/JP and FP and as per customer’s in-house specification.Also available in Microfine.